Switching To or From Cialis (Tadalafil): What Patients and Clinicians Report

Why Men Switch PDE5 Inhibitors

Most men who switch to tadalafil do so because they want a longer window of action. Tadalafil's 17.5-hour half-life means clinically meaningful erectile support can persist for up to 36 hours after a single dose, compared with 4 to 6 hours for sildenafil and 4 to 5 hours for vardenafil 1.

That difference changes how couples plan intimacy. In the key Brock et al. trial (N=1,112), 81% of men on tadalafil 20 mg reported improved erections on the Global Assessment Question, and the drug maintained efficacy from 30 minutes post-dose through 36 hours 1. Sildenafil works. So does vardenafil. But both require dosing within a narrow pre-activity window, and that constraint is the single most cited reason for switching in patient forums.

The 2018 American Urological Association (AUA) guideline on erectile dysfunction states: "Patients who fail to respond to one PDE5 inhibitor may respond to another; clinicians should consider a trial of a different PDE5 inhibitor before moving to second-line therapy" 2. A secondary reason for switching is side-effect profile. Sildenafil and vardenafil more commonly produce visual disturbances (blue-tinted vision) due to cross-reactivity with PDE6, while tadalafil is more selective for PDE5 and PDE11, which shifts the side-effect pattern toward back pain and myalgia instead 3.

Sildenafil to Tadalafil: The Most Common Switch

The sildenafil-to-tadalafil switch accounts for the majority of PDE5i transitions in both clinical data and patient self-reports. The conversion is straightforward: tadalafil 10 to 20 mg on-demand replaces sildenafil 50 to 100 mg, with no washout period required beyond waiting roughly 24 hours (five half-lives of sildenafil) if you want zero pharmacologic overlap.

In practice, most prescribers simply start the new drug without a formal gap. A 2006 crossover preference study by Eardley et al. (N=291) found that 71% of men who tried both drugs preferred tadalafil over sildenafil, citing duration and spontaneity as primary reasons 4. The 29% who preferred sildenafil most often cited faster perceived onset (sildenafil reaches Tmax at roughly 60 minutes vs. 120 minutes for tadalafil) 3.

Reddit's r/Trt and r/erectiledysfunction threads reflect this split. Users who switch to tadalafil frequently describe what one r/Trt poster called "not having to plan around a pill." Users who switch back to sildenafil tend to report that sildenafil produced a subjectively stronger acute effect, though controlled trial data show comparable efficacy rates between the two drugs at equipotent doses 5.

One important caveat about patient forum data: these accounts carry inherent selection bias. Men who post about switching are disproportionately those with strong positive or negative experiences. The large silent middle, men for whom either drug works adequately, rarely posts.

On-Demand vs. Daily Tadalafil: Switching Within the Same Drug

Switching from on-demand tadalafil (10 or 20 mg) to daily tadalafil (2.5 or 5 mg) is its own category of transition, and one that clinicians increasingly recommend. The daily regimen maintains a steady-state plasma concentration after approximately five days 6.

Dr. Irwin Goldstein, director of San Diego Sexual Medicine, has noted: "Daily tadalafil removes the transactional nature of taking a pill before sex. For men with frequent sexual activity or concurrent BPH symptoms, the daily approach often improves both adherence and satisfaction."

The clinical case for daily dosing rests on two FDA-approved indications. Tadalafil 5 mg daily is approved for both ED and benign prostatic hyperplasia (BPH/LUTS). A pooled analysis of four randomized trials (N=1,500) found that daily tadalafil 5 mg improved International Prostate Symptom Score (IPSS) by 4.8 points vs. 2.2 for placebo, while simultaneously maintaining erectile function 7. For men over 45 with both conditions, this dual benefit often makes the daily-to-daily switch a one-drug-two-problems solution.

The pharmacokinetic tradeoff is peak vs. trough. On-demand 20 mg produces a Cmax of roughly 378 ng/mL. Daily 5 mg produces a steady-state Cmax of approximately 77 ng/mL 6. Some men report that on-demand dosing feels "stronger" for a planned encounter, while daily dosing provides more reliable baseline function. Neither approach is objectively superior for all patients.

Switching From Tadalafil to Another PDE5 Inhibitor

Not every switch goes toward tadalafil. Some men move away from it. The most common reasons include persistent back pain or myalgia (reported in 6% to 8% of tadalafil users in clinical trials vs. under 1% with sildenafil), food timing preferences (sildenafil's absorption is reduced by fatty meals, but some men prefer that predictability), and a subjective preference for sildenafil's faster onset 1.

Avanafil (Stendra) is a newer option that some men switch to from tadalafil when speed of onset is the priority. Avanafil reaches Tmax in 30 to 45 minutes with higher PDE5 selectivity than sildenafil 8. The tradeoff is a shorter duration of action (approximately 6 to 8 hours) and higher cost, since generic avanafil is not yet widely available in 2026.

When switching away from daily tadalafil, there is no rebound effect or withdrawal phenomenon, but tadalafil's long half-life means residual drug levels persist for 3 to 4 days. Prescribers typically advise starting the new PDE5i the day after the last tadalafil dose, acknowledging some pharmacologic overlap during the transition.

What Reddit and Patient Forums Report About Switching

Patient self-reports on Reddit (r/Trt, r/erectiledysfunction, r/AskMen), Drugs.com reviews, and similar platforms follow a consistent pattern across hundreds of posts. Tadalafil earns a 4.2 out of 5 average on Drugs.com (based on over 900 reviews for ED as of early 2026), compared with 3.9 for sildenafil 9.

The most frequent themes in switching reports:

Positive reports (tadalafil switchers). Spontaneity is the dominant theme. Users describe "weekend coverage" from a single Friday dose. Men on TRT who add daily tadalafil 5 mg frequently report improved gym pumps and lower blood pressure readings as secondary benefits, consistent with tadalafil's mild vasodilatory effect. Multiple r/Trt threads describe this combination as a "quality of life upgrade."

Negative reports (switching away from tadalafil). Back pain and nasal congestion are the two complaints that most often drive men back to sildenafil. Some users describe a "too subtle" effect from daily 5 mg, preferring the more pronounced acute response of on-demand sildenafil 100 mg. A smaller subset reports flushing or headache that persists for hours due to tadalafil's long half-life, making side effects harder to "wait out" compared with sildenafil.

Mixed reports. A recurring pattern: men try tadalafil, find it works but produces different side effects, then alternate between tadalafil for weekends and sildenafil for planned encounters. This alternating approach is not well-studied in clinical trials but is common in practice and is not contraindicated.

Sample size limitations apply to all forum data. Drugs.com's 900+ tadalafil reviews represent a self-selected population. The true denominator of tadalafil users in the U.S. numbers in the millions, so forum reports capture the tails of the experience distribution, not the center.

Dose Equivalence and Conversion Guide

No FDA-approved dose conversion table exists between PDE5 inhibitors. The approximate clinical equivalences used in practice are based on comparative efficacy trials and pharmacokinetic modeling 5.

Approximate on-demand equivalences:

• Sildenafil 25 mg corresponds to tadalafil 5 mg
• Sildenafil 50 mg corresponds to tadalafil 10 mg
• Sildenafil 100 mg corresponds to tadalafil 20 mg
• Vardenafil 10 mg corresponds to tadalafil 10 mg
• Vardenafil 20 mg corresponds to tadalafil 20 mg
• Avanafil 100 mg corresponds to roughly tadalafil 10 mg
• Avanafil 200 mg corresponds to roughly tadalafil 20 mg

These are rough guides. Individual response varies substantially based on CYP3A4 metabolism, body weight, and degree of endothelial dysfunction. The AUA recommends starting at the middle dose of the new agent and titrating based on response over two to three attempts 2.

For men switching to daily tadalafil, the FDA-approved starting dose is 2.5 mg once daily, titrated to 5 mg based on tolerability. Starting at 5 mg daily is common in clinical practice when the patient has already tolerated on-demand tadalafil 10 mg or higher.

Drug Interactions to Reassess When Switching

Every PDE5i switch requires a medication interaction review, but tadalafil's longer half-life makes certain interactions more clinically relevant. The concurrent use of nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) is absolutely contraindicated with all PDE5 inhibitors. The difference: after a sildenafil dose, the nitrate-free interval is 24 hours; after tadalafil, it extends to 48 hours due to the longer half-life 10.

Alpha-blockers (tamsulosin, doxazosin, alfuzosin) require careful coordination. Tadalafil's FDA label recommends that patients on alpha-blockers begin with the 5 mg dose, and only when the alpha-blocker dose is stable 10. CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, grapefruit juice in large quantities) increase tadalafil exposure. With strong CYP3A4 inhibitors, the maximum recommended tadalafil dose drops to 10 mg per 72 hours on-demand, or daily dosing should not exceed 2.5 mg 10.

Men switching from sildenafil to tadalafil while on an antihypertensive regimen should monitor blood pressure during the first week, as the additive vasodilatory effect persists longer with tadalafil.

When Switching is Not Enough: Recognizing PDE5i Non-Response

Approximately 30% to 35% of men with ED do not respond adequately to any PDE5 inhibitor 11. Before concluding that a switch has failed, clinicians should verify proper usage: the drug was taken on an empty or low-fat stomach (for sildenafil/vardenafil), adequate sexual stimulation was present, and at least four to six attempts were made at the maximum tolerated dose.

Dr. Arthur Burnett, professor of urology at Johns Hopkins, has stated: "True PDE5 inhibitor failure should be diagnosed only after confirming proper dosing technique and an adequate number of attempts. Many apparent non-responders are actually non-optimized users" 11.

For confirmed non-responders, second-line options include intracavernosal injection therapy (alprostadil, trimix), vacuum erection devices, or penile prosthesis surgery. Combination therapy with a PDE5i plus low-dose intracavernosal alprostadil is another approach with emerging evidence 12.

Testosterone status should also be checked. Men with total testosterone below 300 ng/dL have lower PDE5i response rates, and testosterone replacement therapy may restore responsiveness to tadalafil or sildenafil in hypogonadal men 13.

Switching on TRT: Special Considerations

Men receiving testosterone replacement therapy (TRT) represent a growing subpopulation of PDE5i users. Testosterone and PDE5 inhibitors act through complementary pathways: testosterone upregulates nitric oxide synthase expression, while PDE5 inhibitors prevent cyclic GMP degradation downstream 13.

A meta-analysis by Corona et al. (2017) pooled 14 RCTs (N=2,029) and found that the combination of testosterone and PDE5 inhibitors produced significantly greater IIEF improvements than either treatment alone, with a weighted mean difference of 2.4 IIEF points favoring combination therapy 14. For men on TRT who find sildenafil inadequate, switching to daily tadalafil 5 mg often addresses three concerns simultaneously: erectile function, BPH symptoms (common in the over-50 TRT population), and the exercise-related vasodilatory benefits that TRT patients frequently seek.

The r/Trt community reflects this clinical data. Daily low-dose tadalafil is one of the most commonly discussed adjunct medications in that forum, with users reporting improved erection quality and reduced post-exercise soreness as the primary benefits.

Timeline Expectations After Switching

On-demand tadalafil works with a single dose. Daily tadalafil requires 4 to 5 days to reach steady-state plasma concentration 6. Men switching from on-demand sildenafil to daily tadalafil 5 mg should expect a 3 to 5 day ramp-up before the full effect stabilizes. During this transition, some prescribers offer a single on-demand tadalafil 10 mg dose as a "bridge" while steady-state builds, though this approach is off-label and not universally recommended.

For men switching between on-demand agents (e.g., sildenafil 100 mg to tadalafil 20 mg), the new drug can be used at the next planned sexual encounter with no gap required. The AUA guideline recommends trialing at least six doses of the new PDE5i before judging efficacy, as performance anxiety and dosing unfamiliarity can confound early attempts 2.